Oregon City, Oregon Clinical Trials

A listing of Oregon City, Oregon clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 42 clinical trials
Study Details  

 

Portland Site
 (6.7 away)
  • 0 views
  • 19 Feb, 2024
  • 1 location
2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

medical therapy
tricuspid valve replacement
Oregon Health & Science University
 (9.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma

This is a single-arm, open-label, multicenter, Phase 1 study evaluating the safety and efficacy of CTX120 in subjects with relapsed or refractory multiple myeloma.

refractory multiple myeloma
multiple myeloma
Research Site 3
 (9.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy …

leucovorin
celiac
solid tumor
hiv test
MRI
Clackamas Radiation Oncology Center
 (4.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +254 other locations
Expanded Access of Omidubicel for Allogeneic Transplantation in Patients With Hematological Malignancies

Omidubicel is an investigational therapy for patients with high-risk hematologic malignancies.

allogeneic transplantation
investigational treatment
hematologic malignancy
cancer
Oregon Health & Science University
 (9.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

iobenguane
refractory hepatoblastoma
recurrent childhood rhabdomyosarcoma
platelet count
pediatric
Oregon Health and Science University
 (9.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +82 other locations
Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy

The objective of this proposal is to investigate the effect of non-invasive repetitive cerebellar transcranial magnetic stimulation (rTMS) on motor control in progressive supranuclear (PSP). The central hypothesis is that augmenting cerebellar inhibition via cerebellar rTMS will decrease postural instability in patients with PSP by increasing functional connectivity between the …

dopamine
transcranial magnetic stimulation
progressive supranuclear palsy
speech therapy
Oregon Health & Science University
 (9.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Clinical and Genetic Analysis of ROP

Retinopathy of Prematurity (ROP) is a vascular disease affecting the retinas (back of the eye) of low birth weight infants. Although it can be treated effectively if diagnosed early, it continues to be a leading cause of childhood blindness in the United States and throughout the world. The investigators feel …

genetic analysis
strabismus
premature birth
vascular disease
prematurity
Oregon Health & Science University
 (9.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +4 other locations
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

tremor
modafinil
parkinson's disease
resting tremor
bradykinesia
Oregon Health &Science University
 (9.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +45 other locations
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

This trial collects research data and samples from patients who experience immunotherapy side effects to store for use in future research studies. Studying research data and samples from patients who experience immunotherapy side effects may help researchers better understand how to predict, prevent, and treat these side effects.

biospecimen collection
Clackamas Radiation Oncology Center
 (4.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +380 other locations